Adenosine-Augmentation Therapies (AAT's) for Epilepsy Therapy
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
R.S. Dow Neurobiology Laboratories and Legacy Research Institute, Epilepsy Foundation (EF),CURE
Mechanism of Action
Other
Mechanism Description
silk-based polymers have been bioengineered to release adenosine
Populations Tested In
Focal Seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2006;
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link